It is our great pleasure to invite you to take part at MSS2026. Join us!
MSS2026 focuses on production solutions across the full journey—from development to manufacturing—together with advanced analytics for gene therapies, vaccines, and complex biological products such as plasma, proteins, and enzymes.
The symposium covers the entire workflow, from upstream to downstream processing, in a hybrid format that supports both onsite and online participation.
MSS2026 Speakers
Andre Germishuizen
National Bioproducts Institute (NBI)
Commercial-Scale Evaluation of a CIMmultus® Mixed-Mode Monolith for IgG Production
Jacek Lubelski
NanoCell
tLNP as a Novel Gene Therapy Vector to Deliver DNA
Manuela Bartolini
Alma Mater Studiorum University of Bologna
Monolith-based immobilised enzyme reactors: enabling technologies across evolving analytical and biotechnological landscapes
Dan Peer
Laboratory of Precision Nanomedicine, Tel Aviv University
The RNA revolution: from novel vaccines to therapeutic genome editing
Aleš Štrancar
BIA Separations Inc
Away from Cohn, away from EtOH, the next generation plasma fractionation process
Stefano Menegatti
North Carolina State University
Affinity and mixed-mode convective adsorbents for the purification and enrichment of vectors for cell and gene therapies
Thomas Muster
BlueSky Immunotherapies
Interferon-inducing viral vector immunotherapy reprograms tumor immunity and eliminates persistent HPV infection
REGISTER
MSS2026 is about Bridging Science, Innovation and Manufacturing in Bioprocessing and Biopharma. Will you be part of it?
REGISTER HERE
CONNECT WITH US
Help us grow a LinkedIn community of experts working in gene therapies, vaccines, and other biological products. Get event updates, special offers, discounts, and more.
MSS2024 OVERVIEW
Take a look at previous editions and hear what past participants had to say.
GET A MSS2024 OVERVIEW
